Aviptadil

Vasoactive Intestinal Peptide (VIP) AnalogRx: InvestigationalCompound: Investigational

Also known as: Phentolamine/VIP, RLF-100, RLF‑1, Synthetic VIP, Vasoactive Intestinal Peptide, VIP, ZYESAMI

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Aviptadil at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Synthetic 28‑amino‑acid peptide derived from vasoactive intestinal peptide, investigated for acute respiratory distress syndrome, COVID‑19–related lung injury, pulmonary hypertension and heart failure.

Mechanism of Action

Agonist of VPAC1 and VPAC2 receptors, producing vasodilation, bronchodilation, anti‑inflammatory and cytoprotective effects in lung and cardiovascular tissues

Routes of Administration

InhalationInhaledIntravenousSubcutaneous

Goals & Uses

  • COVID‑19 severe pneumoniaInfectiousModerate
  • Erectile dysfunctionSexual HealthLow
  • Sarcoidosis-related respiratory failureRespiratoryLow
  • COVID-19-associated respiratory failureInfectious Disease / RespiratoryModerate
  • Cytokine storm suppressionImmunomodulationModerate
  • Pulmonary arterial hypertension (PAH)Cardiovascular / PulmonaryLow
  • Acute Respiratory Distress Syndrome (ARDS)RespiratoryModerate
  • Pulmonary hypertensionCardiovascularLow

Contraindications

  • PregnancyPopulationModeratePotential fetal risk or insufficient safety data
  • Known hypersensitivity to aviptadil or any peptide excipientsAllergyHigh
  • Hypersensitivity to VIP or aviptadilAllergyHigh
  • Uncontrolled cardiac arrhythmiasCardiovascularModerate
  • Severe hypotension (SBP <90 mmHg)HemodynamicModerate
  • Severe hypotensionCardiovascularHigh

Adverse Effects

  • Injection site reactionsLocalUncommon
  • HeadacheNeurologicUncommonPain in the head or upper neck
  • HypotensionCardiovascularCommonLow blood pressure
  • FlushingVascularCommonWarmth and redness of the skin
  • TachycardiaCardiovascularUncommonAbnormally fast heart rate
  • NauseaGastrointestinalUncommonFeeling of sickness or urge to vomit
  • DiarrheaGastrointestinalUncommonLoose or frequent stools

Drug Interactions

  • Antihypertensive agentsModerate
  • Other vasodilators (e.g., nitroglycerin, ACE inhibitors)Moderate
  • CYP‑metabolized drugsLow
  • CorticosteroidsLow
  • Vasopressors (e.g., norepinephrine)Low
  • Phosphodiesterase-5 inhibitors (e.g., sildenafil)High

Population Constraints

  • PregnancyReproductive SafetyRelative
  • Renal impairmentOrgan ImpairmentRelative
  • Pediatric patientsAgeRelative
  • Pediatrics (<12 years)AgeRelative
  • Patients with pre-existing severe hypotensionCardiovascularRelative
  • Pregnant womenReproductiveRelative
  • Elderly patients (≥65 years)Age RelatedRelative

Regulatory Status

  • European UnionUnapprovedNo marketing authorization
  • United StatesInvestigationalIND status; not FDA‑approved
  • United KingdomUnapprovedNot licensed for clinical use

Received FDA Breakthrough Therapy Designation for treatment of COVID-19-associated respiratory failure. Not currently FDA-approved for any indication. Studied under Emergency Use Authorization context during COVID-19 pandemic. Orphan drug designation in EU for pulmonary arterial hypertension.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is Aviptadil?

Synthetic 28‑amino‑acid peptide derived from vasoactive intestinal peptide, investigated for acute respiratory distress syndrome, COVID‑19–related lung injury, pulmonary hypertension and heart failure.

What is Aviptadil used for?

Aviptadil is educationally associated with: COVID‑19 severe pneumonia, Erectile dysfunction, Sarcoidosis-related respiratory failure, COVID-19-associated respiratory failure, Cytokine storm suppression, Pulmonary arterial hypertension (PAH), Acute Respiratory Distress Syndrome (ARDS), Pulmonary hypertension. Educational only — not medical advice.

How is Aviptadil administered?

Recorded routes of administration: Inhalation, Inhaled, Intravenous, Subcutaneous.

What are the potential side effects of Aviptadil?

Reported adverse effects include: Injection site reactions, Headache, Hypotension, Flushing, Tachycardia, Nausea, Diarrhea. This list is not exhaustive — consult a qualified clinician.

Who should avoid Aviptadil?

Recorded contraindications: Pregnancy, Known hypersensitivity to aviptadil or any peptide excipients, Hypersensitivity to VIP or aviptadil, Uncontrolled cardiac arrhythmias, Severe hypotension (SBP <90 mmHg), Severe hypotension. Consult a qualified clinician before use.